1 Min Read Chronic Inflammation and Cancer
July 8, 2026Chronic Inflammation and Cancer
July 8, 2026
Care Framework & Diagram
There's a cancer risk you accumulate or spend down every day — it's called chronic inflammation burden
A
Act Now — Confirmed Causal
H. pylori (stomach), HBV/HCV (liver), and IBD (colon) are confirmed causes — treatment cuts cancer risk 46–80%.
• Action: Get screened (breath test / hepatitis panel), then treated.
B
Strongly Recommended — Probable Causal
Abdominal obesity (13 cancer types) and gum disease (pancreatic, esophageal cancer) both carry strong evidence.
• Action: Lose 5–10% weight, get annual dental care, quit smoking.
C
Worth Practicing — Preliminary Evidence
Poor sleep, gut imbalance, and chronic stress all measurably weaken cancer surveillance.
• Action: 7–9 hrs sleep, Mediterranean diet, exercise, stress management.
Frequently Asked Questions
I tested positive for H. pylori but have no symptoms — do I need treatment?
Current mainstream consensus (including China consensus opinions and Asia-Pacific consensus) is: unless there are clear contraindications, adults testing H. pylori positive are recommended to receive eradication treatment, regardless of symptoms. Eradication therapy is usually ten to fourteen days of triple or quadruple antibiotic combination (proton pump inhibitor + two antibiotics), with eradication success rates of eighty to ninety percent under standardized treatment. Over four weeks after treatment ends, a breath test is needed to confirm successful eradication.
I have hepatitis B but normal liver function — do I need treatment?
Not necessarily immediately, but regular follow-up is essential. Whether treatment is needed depends on multiple factors: HBV DNA level (viral load), HBeAg status, degree of hepatic inflammation and fibrosis, and age and family history. Patients with normal liver function but high viral load or signs of liver fibrosis are usually advised to start antiviral treatment. Develop an individualized plan under hepatologist guidance — don't ignore follow-up just because 'liver function is normal.'
CRP is elevated — how should I address it?
First distinguish between hs-CRP and regular CRP, and between acute elevation versus sustained elevation. A single CRP elevation (especially with recent infection, surgery, or other acute event) has no diagnostic meaning for chronic inflammation. If after excluding acute causes, hs-CRP still persistently exceeds 1 mg/L, actively find and address chronic inflammation sources: screen for H. pylori and hepatitis; assess weight and waist circumference; check periodontal health; evaluate sleep and stress status. The focus is eliminating sources, not simply trying to 'lower the CRP number.'
How often should ordinary people screen for H. pylori?
No fixed screening interval recommendation for all ordinary people. Recommend active testing in these situations: digestive symptoms (upper abdominal pain, acid reflux, belching); family history of gastric cancer; from H. pylori high-prevalence regions; history of gastric or duodenal ulcers; planning long-term NSAID use. If already eradicated successfully, generally no routine retest needed unless symptoms recur.
What checks should periodontal disease patients have for systemic cancer risk?
Periodontal disease itself isn't an indication for tumor-specific testing — it's a signal to take systemic chronic inflammation more seriously. Practical recommendations: treat the periodontal disease (professional cleaning at least once a year, subgingival scaling as needed); test hs-CRP to understand systemic inflammation level; complete standardized cancer screening (colorectal cancer from age 45). Integrate 'dental health' into overall health management.